false
English
Catalog
2021 World Conference on Lung Cancer (WCLC) Highli ...
WCLC 2021 Highlights
WCLC 2021 Highlights
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The webinar discussed the highlights of the World Conference on Lung Cancer 2021. The speakers presented various topics related to lung cancer treatment and research. The webinar focused on several key trials, including the Poseidon trial, which compared different treatment options for non-small cell lung cancer. The trial found that chemotherapy with Druvolumab and Tremolumab was likely to become a first-line option. The Atlantis trial, on the other hand, evaluated the use of Lubarekton in combination with other drugs for small cell lung cancer. The trial did not show significant benefit in terms of overall survival. The webinar also discussed the treatment of brain metastasis in lung cancer patients and the role of chemotherapy and immunotherapy in these cases. Another topic of discussion was the impact of the COVID-19 pandemic on international lung cancer clinical trials. The survey study found that clinical trial enrollment decreased by 43% during the pandemic. The webinar also addressed the issue of healthcare disparities in lung cancer care, particularly in the United States. The speakers emphasized the need for comprehensive approaches to address these disparities and highlighted innovative programmatic solutions. Finally, the webinar explored the global burden of lung cancer attributable to air pollution. The study found that air pollution accounts for 14% of all lung cancer deaths worldwide. Overall, the webinar offered important insights into the latest advancements and challenges in lung cancer research and treatment.
Keywords
World Conference on Lung Cancer 2021
lung cancer treatment
Poseidon trial
non-small cell lung cancer
chemotherapy
Druvolumab
Tremolumab
Atlantis trial
small cell lung cancer
air pollution
×
Please select your language
1
English
5
普通话
11
Dutch